Skip to main content
Jamie Felton, MD, Pediatric Endocrinology, Indianapolis, IN

Jamie Lynn Felton MD


Physician

Join to View Full Profile
  • 705 Riley Hospital Dr# RI5960Indianapolis, IN 46202

  • Phone+1 317-944-3889

  • Fax+1 317-944-3882

Dr. Felton is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterFellowship, Pediatric Endocrinology, 2014 - 2017
  • University of North Carolina Hospitals
    University of North Carolina HospitalsResidency, Pediatrics, 2011 - 2014
  • The University of Texas Health Science Center at San Antonio
    The University of Texas Health Science Center at San AntonioClass of 2011

Certifications & Licensure

  • IN State Medical License
    IN State Medical License 2018 - 2025
  • TN State Medical License
    TN State Medical License 2014 - 2020
  • NC State Medical License
    NC State Medical License 2011 - 2014
  • Pediatrics
    American Board of Pediatrics Pediatrics
  • Pediatric Endocrinology
    American Board of Pediatrics Pediatric Endocrinology

Publications & Presentations

PubMed

Journal Articles

  • Anti-Insulin B Cells Are Poised for Antigen Presentation in Type 1 Diabetes  
    Jamie L Felton, James W Thomas, The Journal of Immunology

Press Mentions

  • $1.1 Million Grant to Help Researchers Improve Type 1 Diabetes Screening in Indiana
    $1.1 Million Grant to Help Researchers Improve Type 1 Diabetes Screening in IndianaJanuary 14th, 2025
  • IU Research Contributes to First FDA-approved Drug to Delay Onset of Type 1 Diabetes
    IU Research Contributes to First FDA-approved Drug to Delay Onset of Type 1 DiabetesNovember 21st, 2022
  • Fishers Boy First in Indiana to Receive Newly Approved Drug That Delays Onset of Type 1 Diabetes
    Fishers Boy First in Indiana to Receive Newly Approved Drug That Delays Onset of Type 1 DiabetesSeptember 1st, 2023

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: